French CNRS researchers with a group of scientists from Institut Curie and INSERM have used two-photon microscopy to demonstrate, for the first time in vivo and real-time, how T lymphocytes infiltrate a solid tumour in order to fight it. How is a tumour destroyed by T lymphocytes? This scenario has recently been visualised and published in the journal of Experimental Medicine.
Dr. Vafa Shahabi and her research team at Advaxis have designed several new strains of the Listeria bacteria that are programmed to kill off specific cancers.
Shire plc and its collaborative partner New River Pharmaceuticals Inc., announce the U.S. Food and Drug Administration has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of attention deficit hyperactivity disorder. VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body.
Use of growth hormone to boost athletic performance can lead to diabetes, reports a study published ahead of print in the British Journal of Sports Medicine.
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the New England Journal of Medicine.
Heavy drinking among university students appears to be a universal problem. Although most universities have alcohol policies, it is unclear which interventions can effectively reduce alcohol consumption. A new Swedish study indicates that students who engage in high-risk alcohol consumption benefit the most from a skills-training program.
A draft of proposals which together add up to the loss of professionally-led medical regulation have the potential to muzzle doctors in their role of speaking out for their patients, warns the British Medical Association (BMA).
Multiple sclerosis (MS) female patients tends to go into remission while they are pregnant, according to University of Calgary researchers.
The King?s Fund broadly welcomed the government?s White Paper on the regulation of doctors and other health care professionals, hailing the proposals as a good deal for patients, the public and the medical profession.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).